Kumar Sharma, MD
Enriched profileChief, Division of Nephrology; Vice Chair for Research, Department of Medicine; David L. Hillis Endowed Distinguished Chair in Medicine · The University of Texas Health Science Center at San Antonio
Kumar Sharma is Chief, Division of Nephrology; Vice Chair for Research, Department of Medicine; David L. Hillis Endowed Distinguished Chair in Medicine at The University of Texas Health Science Center at San Antonio. OpenAlex indexes 471 publications with 31,593 citations (h-index 92); ClinicalTrials.gov lists 9 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.
Data verified 14 Aug 2026
Overview
Updated 27 Aug 2026
Kumar Sharma, MD, is Chief, Division of Nephrology at The University of Texas Health Science Center at San Antonio (UT Health San Antonio). The public record shows 471 publications with 31,593 citations (h-index 92), centered on Chronic Kidney Disease and Diabetes, Methane Hydrates and Related Phenomena, Pancreatic function and diabetes. It also documents an investigator role on 9 registered clinical trials, industry payments reported by 9 companies, 8 NIH-funded awards (2017–2026).
- Most recent indexed publication: 2026 · Nature reviews. Nephrology
- Top research focus: Chronic Kidney Disease and Diabetes
- 9 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 18 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 228.
Clinical & industry
trials, payments and federal fundingPublic positions
sourced statements on record- Member
Governor's Chronic Kidney Disease Task Force, Texas (since 2020); contributor to the Texas HHS State Plan for Chronic Kidney Disease Treatment
2020verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu ↗
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 9 registered studies on ClinicalTrials.gov. The most recent:
- Mental Health and Periodontitis in Probable Bruxers
Sponsor: Postgraduate Institute of Dental Sciences Rohtak
- Motivational Interviewing and Subgingival Instrumentation Outcomes in Periodontitis
Sponsor: Postgraduate Institute of Dental Sciences Rohtak
- Impact of Distress Level, Sleep Quality and Occlusal Trauma on Periodontal Status Among Bruxers
Sponsor: Postgraduate Institute of Dental Sciences Rohtak
Industry payments
Updated 27 Aug 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Calliditas Therapeutics US Inc.Program year20251 payment
- Novartis Pharmaceuticals CorporationProgram year20241 payment
- Novo Nordisk IncProgram year20241 payment
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
58.7%Angiotensin receptor blocker (ARB)31.6%Losartan Potassium100%Part D≥23 patientsLoop diuretic14.6%Furosemide69%Torsemide31%Part D<11 patientsMetabolism & gastrointestinal
35.4%SGLT2 inhibitor31.2%Farxiga79%Jardiance21%Part D<11 patientsVitamin D3 Analog4.2%Calcitriol100%Part D<11 patientsMusculoskeletal
5.9%Xanthine oxidase inhibitor5.9%Allopurinol100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
8 NIH research awards on record, funded 2017–2026 per NIH RePORTER. The latest:
- Metabolite Markers of Diabetic Kidney Disease
University of Texas Hlth Science Center
FY2026$825,255R01DK143234 - Renewal: Pannexin-1 signaling in abdominal aortic aneurysms
University of Florida
FY2026$694,879R01HL138931 - Spatial Multi-Omics to Profile Metabolic Pathways for Kidney Disease
University of Texas Hlth Science Center
FY2026$619,452U01DK114920
Congress activity
Updated 27 Aug 2026
9 congress contributions (2015–2023) across ADA, ENDO per OpenAlex. The most recent:
- 1095-P: Proteomic Analyses Identify Novel Predictors of Loss of Glycemic Control in Youth-Onset Type 2 Diabetes
ADA Scientific Sessions
ADA2023Co-authorPoster - 1096-P: Plasma Metabolites Predict Loss of Glycemic Control in Youth with Type 2 Diabetes (T2D)
ADA Scientific Sessions
ADA2023Co-authorPoster - 12-OR: Urine Lactate Is a Disease Biomarker for Diabetic Kidney Disease
ADA Scientific Sessions
ADA2023Co-authorOral
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Spatial metabolomics and multiomics integration for breakthroughs in precision medicine for kidney disease.
Nature reviews. Nephrology
Review2026 - Inhibition of methylthioadenosine phosphorylase protects from experimental acute kidney injury.
American journal of physiology. Renal physiology
Article2025 - Imaging and spatially resolved mass spectrometry applications in nephrology.
Nature reviews. Nephrology
Review2025 - Proteomic Analysis Uncovers Multiprotein Signatures Associated with Early Diabetic Kidney Disease in Youth with Type 2 Diabetes Mellitus.
Clinical journal of the American Society of Nephrology
Article2024
Most-cited works
by citation count (OpenAlex)- 01
- 02Diabetic kidney disease1,212 citations2015
- 03
- 04
Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/pub/kumar-sharma-md
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - LinkedIn
linkedin.com/in/kumar-sharma-963817101
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
scholars.uthscsa.edu/en/persons/kumar-sharma
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scholars.uthscsa.edu ↗
Mentions by others
where others cite or feature them- Facebook
facebook.com/UTHealthSANeph
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - LinkedIn
linkedin.com/company/center-for-precision-medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - Other
foxsanantonio.com/news/local/ut-health-san-antonio-discovers-molecule-predicting-kidney-failure-in-diabetics
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →foxsanantonio.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lsom.uthscsa.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu ↗
- Board Certified
American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →directory.uthscsa.edu ↗
Editorial & leadership roles
journal and society appointments- Editorial Board Member
American Journal of Nephrology (Karger)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →karger.com ↗ - Standing Member
NIH Pathology of Kidney Disease study section
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lsom.uthscsa.edu ↗ - Lead investigator role
NIH Kidney Precision Medicine Project (national hub for spatial metabolomic profiling of kidney tissue)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.uthscsa.edu ↗
Awards & honors
honors on the public record- Translational STARs Award
The University of Texas System, $1.4 million (2017), to establish the Center for Renal Precision Medicine
2017verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.uthscsa.edu ↗ - Fellow
American Heart Association (FAHA)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lsom.uthscsa.edu ↗ - Fellow
American Society of Nephrology (FASN)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lsom.uthscsa.edu ↗
Secondary affiliations
appointments beyond the home institution- Director
Center for Renal Precision Medicine (formerly Center for Precision Medicine), UT Health San Antonio
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lsom.uthscsa.edu ↗ - Faculty
Department of Cellular and Integrative Physiology, UT Health San Antonio
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →lsom.uthscsa.edu ↗
Media & interviews
press, podcasts and appearances- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →wp.uthscsa.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →youtube.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
Alexander Parikh, MD, MPH
The University of Texas Health Science Center at San Antonio
Boulos Toursarkissian, MD
The University of Texas Health Science Center at San Antonio
Lee Birnbaum, MD
The University of Texas Health Science Center at San Antonio
Clinton Baisden, MD
The University of Texas Health Science Center at San Antonio